-
-
Call more information
660-596-2224 -
ASA Monitor June 2023, Vol. 87, 16–17. Trends Artificial pancreas improves blood glucose control in young children by 12% In the NIH-funded Pediatric Artificial Pancreas (PEDAP) Trial, artificial pancreas technology improved blood glucose control in young children between ages 2 and 5 with type 1 diabetes. The study was a 13-week randomized, controlled trial that enrolled […]
Read MoreAuthor Yaras R, Bettinger J. Pract Pain Manage. 2023 MayJune:23(2). How to apply the updated CDC Clinical Practice Guideline for Prescribing Opioids for Pain in patients already on opioid therapy for chronic pain. The following hypothetical case is intended to reflect the changes in the CDC opioid prescribing guidelines (see full background).¹ Below is a step-by-step guide through […]
Read MoreASA Monitor June 2023, Vol. 87, 11–12. The Anesthesia Incident Reporting System (AIRS) was launched in 2011, turning 12 this year. We have thousands of reports letting us know when an anesthetic was associated with a complication. In reviewing the cases in AIRS, one theme we have noted is the persistence of distraction from electronic devices […]
Read MoreASA Monitor June 2023, Vol. 87, 10. A 35-year-old man is admitted to the intensive care unit (ICU) in septic shock after surgery for a perforated appendix. According to a recent study comparing fluid administration strategies in ICU patients in septic shock, which of the following outcomes is MOST likely if this patient is administered a […]
Read MoreAuthors: Jane Ahn, MD et al ASA Monitor June 2023, Vol. 87, 24. Volatile hydrofluorocarbon anesthetics (sevoflurane, isoflurane, and desflurane) and nitrous oxide are ubiquitous in perioperative anesthetic practice and are estimated to contribute between 0.01% to 0.1% of total global greenhouse gas (GHG) emissions (BMJ 2022 8;377:o1301; asamonitor.pub/40kSYby). When used in clinical practice, volatile anesthetics undergo […]
Read More